Fidson Healthcare has declared a N3.6 billion dividend for its shareholders, marking a significant return of capital following a robust first half of 2026.
The payout underscores the company's financial resilience and its ongoing strategic ambition to solidify its position as Africa’s largest pharmaceutical manufacturer.
Fidson reported a 28% year-on-year increase in profit after tax, with net profit rising to N7.
The dividend distribution is supported by strong operational performance in the first six months of the year.
Fidson reported a 28% year-on-year increase in profit after tax, with net profit rising to N7.7 billion.
This growth trajectory highlights the company's ability to navigate the challenging macroeconomic environment in Nigeria while expanding its bottom line.
As the most capitalized firm in the healthcare sector on the Nigerian Exchange (NGX), Fidson’s move signals confidence in its cash flow generation and future prospects.